yingweiwo

NLR

NLR

NLR related products

Structure Cat No. Product Name CAS No. Product Description
(±)11(12)-EET-d11 ((±)11,12-EET-d11) V75174 (±)11(12)-EET-d11 ((±)11,12-EET-d11) 2699607-19-5 (±)11(12)-EET-d11 is the deuterated form of (±)11(12)-EET.
Callicarboric acid A V85981 Callicarboric acid A
COX-2/NLRP3-IN-1 V83500 COX-2/NLRP3-IN-1
D359-0396 V74293 D359-0396 1031977-31-7 D359-0396 is an orally bioactive NLRP3 inflammasome inhibitor.
Human NLRP3 mRNA V118745 Human NLRP3 mRNA Human NLRP3 mRNA encodes the NLRP3 protein, an inflammasome.
IIIM-1270 V117364 IIIM-1270 4818-19-3 IIIM-1270 is an NLRP3 inflammasome inhibitor.
INF39 V2031 INF39 866028-26-4 INF39 (INF-39; INF 39), an acrylate derivative, is a potent, irreversible andnontoxic inhibitor of NLRP3 with potential anti-inflammatory activity.
JT002 V75180 JT002 2238820-43-2 JT002 is an orally bioactive NLRP3 inflammasome inhibitor.
MC-ND-18 V86935 MC-ND-18 MC-ND-18 is a degrader of NLRP3 via autophagy, with a DC50 of 125.5 nM in THP-1 cells.
NLRP3-IN-13 V75162 NLRP3-IN-13 1704638-35-6 NLRP3-IN-13 (referred to as compound C77 in the patent) is a potent and specific NLRP3 inhibitor (IC50= 2.1 μM).
NLRP3-IN-26 V85836 NLRP3-IN-26 2927413-30-5
NLRP3-IN-34 V100280 NLRP3-IN-34 1392502-55-4 NLRP3-IN-34 (compound T10) is an inhibitor of NLRP3 inflammasome.
NLRP3-IN-35 V103930 NLRP3-IN-35 NLRP3-IN-35 (Compound 11) is a NLRP3 inhibitor (IC50 < 1 μM).
NLRP3-IN-42 V86930 NLRP3-IN-42 NLRP3-IN-42 (compound H28) is a potent NLRP3 inhibitor with a KD of 1.15 µM.
NLRP3-IN-54 V94392 NLRP3-IN-54 NLRP3-IN-54 (Compound C4) is a NLRP3 inhibitor.
NLRP3-IN-56 V94338 NLRP3-IN-56 3048421-42-4 NLRP3-IN-56 (Compound 062) is a NLRP3 inhibitor.
NLRP3/AIM2-IN-2 V51066 NLRP3/AIM2-IN-2 791840-86-3 NLRP3/AIM2-IN-2 is a new and potent analogue targeting NLRP3 and AIM2 key body-dependent pyroptosis with different species topology.
NP3-253 V104925 NP3-253 2557349-50-3 NP3-253 is an orally active and blood-brain barrier-permeable NLRP3 inhibitor that can be used as a tool to further explore the biology of NLRP3 in peripheral and neuroinflammatory models.
NP3-742 V115435 NP3-742 NP3-742 is an orally effective NLRP3 inhibitor that binds to the NACHT domain of NLRP3.
NT-0249 free base V86917 NT-0249 free base NT-0249 free base is an orally active NLRP3 inhibitor.
Contact Us